These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6608779)

  • 1. Disappearance of hepatitis B surface antigen in chronic type B hepatitis after clinical and laboratorial relapse produced by abrupt withdrawal of immunosuppressive drugs.
    da Silva LC; Mattar E; Carrilho FJ; Takeda A; Sette Júnior H; Gayotto LC
    Rev Inst Med Trop Sao Paulo; 1983; 25(6):270-4. PubMed ID: 6608779
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis.
    Liaw YF; Chu CM; Su IJ; Huang MJ; Lin DY; Chang-Chien CS
    Gastroenterology; 1983 Feb; 84(2):216-9. PubMed ID: 6848402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B.
    Scullard GH; Smith CI; Merigan TC; Robinson WS; Gregory PB
    Gastroenterology; 1981 Dec; 81(6):987-91. PubMed ID: 7286593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Should chronic active viral hepatitis be treated with drugs or not?].
    Schalm SW
    Internist (Berl); 1981 Dec; 22(12):717-20. PubMed ID: 7033161
    [No Abstract]   [Full Text] [Related]  

  • 5. [Reactivation of hepatitis B following withdrawal of chloroquine].
    Helbling B; Reichen J
    Schweiz Med Wochenschr; 1994 May; 124(18):759-62. PubMed ID: 8202673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrence of hepatitis B surface antigen and antibody in acute and chronic hepatitis B cases.
    Ng KP; Saw TL
    Med J Malaysia; 1994 Jun; 49(2):117-21. PubMed ID: 8090089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunosuppressive therapy of chronic active hepatitis: results of a long-term follow-up].
    Musca A; Cordova C; Barnaba V; Levrero M; Zaccari C; Trinchieri F; Gnecchi M
    Clin Ter; 1983 Jun; 105(5):403-9. PubMed ID: 6872479
    [No Abstract]   [Full Text] [Related]  

  • 8. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.
    Bassendine MF; Chadwick RG; Salmeron J; Shipton U; Thomas HC; Sherlock S
    Gastroenterology; 1981 May; 80(5 pt 1):1016-22. PubMed ID: 7009310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathogenic mechanism of fulminant hepatic failure in HBs Ag carrier after withdrawal of cytotoxic chemotherapy].
    Inoue K; Yoshiba M; Sekiyama K; Koh I; Fujita R
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):467-72. PubMed ID: 12442428
    [No Abstract]   [Full Text] [Related]  

  • 10. [Relationship between the HBs-antigen/antibody system in chronic hepatitis].
    Tăpălagă D; Dumitraşcu D; Szantay I; Jebeleanu L
    Med Interne; 1983; 21(3):181-7. PubMed ID: 6665491
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic B and non-B hepatitis in childhood: review of 25 cases.
    Buts JP; Van Craynest MP; Pinto MJ; Gosseye S; Maldague P; De Meyer R
    Acta Paediatr Belg; 1980; 33(2):111-7. PubMed ID: 7424518
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunosuppressive treatment of patients with chronic active HBsAg positive hepatitis].
    Tanno H; Fay O; Roldán L; Vorovioff J
    Acta Gastroenterol Latinoam; 1982; 12(4):323-32. PubMed ID: 7185230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B surface antigen circulating immune complexes (HBsAg-CICs) in patients with hepatitis B and asymptomatic HBsAg carriers.
    Anh-Tuan N; Novák E
    Clin Exp Immunol; 1981 Feb; 43(2):246-53. PubMed ID: 7273479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive drugs in active chronic hepatitis.
    Drug Ther Bull; 1973 Oct; 11(22):87-8. PubMed ID: 4771788
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic type B hepatitis: clinical course.
    Hoofnagle JH; Davis GL; Hanson RG
    Prog Clin Biol Res; 1983; 143():41-53. PubMed ID: 6669585
    [No Abstract]   [Full Text] [Related]  

  • 16. [What can be said against the management of HBsAg-positive chronic hepatitis using steroids or immunosuppressive agents?].
    Strohmeyer G; Thier W
    Internist (Berl); 1979 Apr; 20(4):188-92. PubMed ID: 374303
    [No Abstract]   [Full Text] [Related]  

  • 17. Spontaneous reactivation of chronic hepatitis B virus infection.
    Davis GL; Hoofnagle JH; Waggoner JG
    Gastroenterology; 1984 Feb; 86(2):230-5. PubMed ID: 6690350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic hepatitis caused by B virus (HBV)].
    Di Nola F; Soranzo ML; Angela GC; Salassa B; Bramato C; Fiorio C; Marino M; Bendiscioli L
    Minerva Med; 1980 Apr; 71(14):1009-26. PubMed ID: 7375013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathogenesis and prognosis of acute hepatitis in diabetics].
    Gref C; Maaz E
    Z Gesamte Inn Med; 1980 Feb; 35(3):112-8. PubMed ID: 7395292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prednisolone in HBsAg-positive chronic active hepatitis.
    N Engl J Med; 1981 Jul; 305(5):281-3. PubMed ID: 7242619
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.